Clinical Trials Browser

Phase 2 × Skin Neoplasms × Eflornithine × Clear all

NCT00204789 2019-12-16

Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients

Phase 2 Completed

Skin Neoplasms

NCT00601640 2017-03-23

Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin

Phase 2 Completed

184 enrolled 9 charts

Skin Neoplasms